Compare FLNA & CIRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FLNA | CIRC |
|---|---|---|
| Founded | 1998 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.8M | 67.3M |
| IPO Year | 2000 | 2019 |
| Metric | FLNA | CIRC |
|---|---|---|
| Price | $0.65 | $0.28 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.50 | N/A |
| AVG Volume (30 Days) | 702.8K | ★ 1.4M |
| Earning Date | 11-11-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 70.65 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,119,000.00 | $78,659.00 |
| Revenue This Year | N/A | $10.37 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.64 | $0.29 |
| 52 Week High | $2.03 | $0.98 |
| Indicator | FLNA | CIRC |
|---|---|---|
| Relative Strength Index (RSI) | 34.93 | 35.29 |
| Support Level | N/A | N/A |
| Resistance Level | $1.05 | $0.80 |
| Average True Range (ATR) | 0.04 | 0.07 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 3.74 | 6.80 |
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.